It’s common for cancer patients to suffer from oral mucositis1

Oral mucositis (OM) is a painful side effect of cancer treatment

OM—an inflammatory response to chemo-radiation toxic effects—can dramatically impact patients’ quality of life. OM impacts a patient’s ability to swallow, speak, eat, and drink. OM can lead to increased healthcare costs and cancer treatment reduction, interruption, or discontinuation.1-4

Nearly half of Americans diagnosed with cancer malignancies will suffer from some degree of mucositis5

OM affects ~90% of patients receiving chemo- and radiation therapy for head and neck cancer1

19% of patients receiving chemo- and radiation therapy for head and neck cancer who have OM may end up hospitalized1

Commonly used treatments for OM that contain numbing agents, like lidocaine, may lead to reinjury and may not provide lasting relief.6

However, there is another way to help your patients prepare for and manage OM.

TREAT OM WITH GELCLAIR
References:
  1. Pulito C, Cristaudo A, La Porta C, et al. Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res. 2020;39(1):210. doi:10.1186/s13046-020-01715-7
  2. Vera-Llonch M, Oster G, Hagiwara M, Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 2006;106(2):329-336. doi:10.1002/cncr.21622
  3. Harris DJ. Cancer treatment-induced mucositis pain: strategies for assessment and management. Ther Clin Risk Manag. 2006;2(3):251-258. doi: 10.2147/tcrm.2006.2.3.251
  4. Data on file. Napo Pharmaceuticals, Inc. 2024.
  5. Sonis ST. Treatment for oral mucositis–current options and an update of small molecules under development. Curr Treat Options Oncol. 2021;22(3):25. doi:10.1007/s11864-021-00823-6
  6. Bensinger W, Schubert M, Ang KK, et al. NCCN Task Force Report. Prevention and management of mucositis in cancer care. J Natl Compr Canc Netw. 2008;6(suppl 1):S1-21; quiz S22-4.